Kindler syndrome
WikiDoc Resources for Kindler syndrome |
Articles |
---|
Most recent articles on Kindler syndrome Most cited articles on Kindler syndrome |
Media |
Powerpoint slides on Kindler syndrome |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Kindler syndrome at Clinical Trials.gov Trial results on Kindler syndrome Clinical Trials on Kindler syndrome at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Kindler syndrome NICE Guidance on Kindler syndrome
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Kindler syndrome Discussion groups on Kindler syndrome Patient Handouts on Kindler syndrome Directions to Hospitals Treating Kindler syndrome Risk calculators and risk factors for Kindler syndrome
|
Healthcare Provider Resources |
Causes & Risk Factors for Kindler syndrome |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Kindler syndrome (also known as "Bullous acrokeratotic poikiloderma of Kindler and Weary, "Congenital poikiloderma with blisters and keratosis,"Congenital poikiloderma with bullae and progressive cutaneous atrophy,"Hereditary acrokeratotic poikiloderma, "Hyperkeratosis–hyperpigmentation syndrome,"Acrokeratotic poikiloderma," and "Weary–Kindler syndrome,Andrews' Diseases of the Skin) is a rare congenital disease of the skin caused by a mutation in the KIND1 gene. Infants and young children with Kindler syndrome have a tendency to blister with minor trauma and are prone to sunburns. As individuals with Kindler syndrome age, they tend to have fewer problems with blistering and photosensitivity. However, pigment changes and thinning of the skin become more prominent.
Kindler syndrome is an autosomal recessive genodermatosis. The KIND1 gene mutated in Kindler syndrome codes for the protein kindlin-1, which is thought to be active in the interactions between actin and the extracellular matrix.[1] Kindler syndrome was first described in 1954 by Theresa Kindler.[2]
References
- ↑ Siegel DH, Ashton GH, Penagos HG, Lee JV, Feiler HS, Wilhelmsen KC, South AP, Smith FJ, Prescott AR, Wessagowit V, Oyama N, Akiyama M, Al Aboud D, Al Aboud K, Al Githami A, Al Hawsawi K, Al Ismaily A, Al-Suwaid R, Atherton DJ, Caputo R, Fine JD, Frieden IJ, Fuchs E, Haber RM, Harada T, Kitajima Y, Mallory SB, Ogawa H, Sahin S, Shimizu H, Suga Y, Tadini G, Tsuchiya K, Wiebe CB, Wojnarowska F, Zaghloul AB, Hamada T, Mallipeddi R, Eady RA, McLean WH, McGrath JA, Epstein EH. Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome. Am J Hum Genet. 2003 Jul;73(1):174-87. Epub 2003 Jun 3. PMID 12789646
- ↑ Kindler, T. Congenital poikiloderma with traumatic bulla formation and progressive cutaneous atrophy. Br J Dermatol. 1954 Mar;66(3):104-11. No abstract available. PMID 13149722